Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Evaluation of tolerance of zidovudine-lamivudine-nevirapine combination in HIV 1 patients in Fann Teaching Hospital in Dakar
Bulletin de la Societe de Pathologie Exotique, Volume 106, No. 4, Year 2013
Notification
URL copied to clipboard!
Description
We conducted a study to evaluate the tolerance of the zidovudine (AZT), lamivudine (3TC) and nevirapine (NVP) combination regimen in HIV-1 patients by a descriptive analytical retrospective study of all HIV-1 patients receiving AZT-3TC-NVP combination between 2008 and 2011. Seventy patients were included. Two thirds of the patients presented at least one side effect (44 cases). The digestive disorders (15 cases) and neuropsychiatric (14 cases) were the most frequent. Epigastralgia (20%), headaches (20%) and arthralgias (13%) were main side effects. A maculo-papular exanthema was noted in three cases. During the follow-up, five patients presented with anemia. No patient presented hepatic cytolysis due to NVP. All the patients followed for more than six months presented a side effect against 29.7% when the duration of treatment was equal to or less than 6 months (p=10-5). Most of the side effects due to the association AZT/3TC/NVP are minor. The evaluation of the clinical and biological tolerance must be maintained during all the follow-up. © 2013 Springer-Verlag France.
Authors & Co-Authors
Fortes-Déguénonvo, Louise
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Diop, Sylvie Audrey G.
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Lèye, Mamadou Makhtar Mbacké
Senegal, Dakar
Université Cheikh Anta Diop de Dakar
Seydi, Moussa
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Dieng, Allé Baba
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Bentaleb, H.
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Diouf, Assane M.
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Lakhe, Ndèye Aïssatou
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Ka, Daye
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Cisse, Viviane Marie Pierre
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Dia-Badiane, Ndèye Méry
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Manga, M. N.
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Ndour, Cheikh Tidiane
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Soumare ́, Masserigné L.
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Diop, Bernard Marcel
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Sow, Papa Salif
Senegal, Dakar
Clinique Des Maladies Infectieuses Ibrahima-diop-mar
Statistics
Citations: 16
Authors: 16
Affiliations: 2
Identifiers
Doi:
10.1007/s13149-013-0315-8
ISSN:
00379085
Research Areas
Health System And Policy
Infectious Diseases
Study Design
Cross Sectional Study
Cohort Study